Back to search

Article

CCL20 and CD8A as diagnostic biomarkers for HBV infection-induced hepatic fibrosis development, including immune infiltration in HBV-LF

2022-09-16

Abstract excerpt

<h4>Background: </h4> Histologically, hepatic fibrosis still occures progressively in chronic hepatitis B patients, even if HBV-DNA is negative or undetectable. The diagnosis of hepatic fibrosis is beneficial to control the development of it or promote the reversal. Liver biopsy is a traumatic diagnosis, which is the gold standard of diagnosis at present. The diagnosis of hepatic fibrosis badly needs diagnostic bi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c25db67-fd8d-5ac2-a3ae-ea6591c54d2a
DOI
10.21203/rs.3.rs-2042069/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CCL20 and CD8A as diagnostic biomarkers for HBV infection-induced hepatic fibrosis development, including immune infiltration in HBV-LFDOI 10.21203/rs.3.rs-2042069/v1
Select a neighboring publication to make it the new centre.